Abeona Therapeutics (ABEO) Retained Earnings (2010 - 2026)

Abeona Therapeutics' Retained Earnings history runs 17 years deep, the most recent figure standing at -$21000.0 for Q1 2026.

• In Q1 2026, Retained Earnings rose 100.0% year-over-year to -$21000.0; the TTM figure through Mar 2026 stood at -$21000.0 (up 100.0% YoY), while the FY2025 annual figure was -$742.1 million, down 9276037.5% from the prior year.
• Retained Earnings was -$21000.0 for Q1 2026 at Abeona Therapeutics, up from -$742.1 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $688.2 million in Q3 2022 to a low of -$825.3 million in Q1 2025.
• Historically, Retained Earnings has averaged -$401.2 million across 5 years, with a median of -$704.4 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Retained Earnings soared 7646933.33% in 2022, then tumbled 9276037.5% in 2025.
• A 5-year view of Retained Earnings shows it stood at -$695.3 million in 2022, then fell by 7.79% to -$749.5 million in 2023, then surged by 100.0% to $8000.0 in 2024, then sank by 9276037.5% to -$742.1 million in 2025, then surged by 100.0% to -$21000.0 in 2026.
• The last three Retained Earnings figures came in at -$21000.0 (Q1 2026), -$742.1 million (Q4 2025), and -$721.6 million (Q3 2025), per Business Quant data.